Systematische ÜbersichtMetaanalyse
TCT-609 GLP-1 Receptor Agonists and Clinical Outcomes After TAVR: A Systematic Review and Meta-Analysis
JACC · 2026-11 · 88 (18) · B258-B259
DOI: 10.1016/j.jacc.2026.09.753 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift JACC, 2026-11. Verfasst von Ermilo Echeverria und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Echeverria, E., Tejeda, A. P. T., & Pastor-Cervantes, J. (2026). TCT-609 GLP-1 Receptor Agonists and Clinical Outcomes After TAVR: A Systematic Review and Meta-Analysis. JACC, 88(18), B258-B259. https://doi.org/10.1016/j.jacc.2026.09.753
Vancouver
Echeverria E, Tejeda APT, Pastor-Cervantes J. TCT-609 GLP-1 Receptor Agonists and Clinical Outcomes After TAVR: A Systematic Review and Meta-Analysis. JACC. 2026;88(18):B258-B259. doi:10.1016/j.jacc.2026.09.753
BibTeX
@article{Echeverria2026,
author = {Echeverria, Ermilo and Tejeda, Alfredo Perez Tagle and Pastor-Cervantes, Juan},
title = {TCT-609 GLP-1 Receptor Agonists and Clinical Outcomes After TAVR: A Systematic Review and Meta-Analysis},
journal = {JACC},
year = {2026},
volume = {88},
number = {18},
pages = {B258--B259},
doi = {10.1016/j.jacc.2026.09.753}
}
EUVIMED